Literature DB >> 17092367

Mixtures of SCFA, composed according to physiologically available concentrations in the gut lumen, modulate histone acetylation in human HT29 colon cancer cells.

Jeannette Kiefer1, Gabriele Beyer-Sehlmeyer, Beatrice L Pool-Zobel.   

Abstract

Intake of fibre has beneficial properties on gut health. Butyrate, a product of bacterial gut fermentation, is thought to contribute to positive effects by retarding growth and enhancing apoptosis of tumour cells. One mechanism is seen in its capacity to modulate histone acetylation and thereby transcriptional activity of genes. Next to butyrate, propionate and acetate are also major products of gut fermentation and together they may exert different potencies of cellular effects than butyrate alone. Since virtually nothing is known on combination effects by SCFA mixtures, here we had the aim to assess how physiological relevant concentrations and mixtures of SCFA modulate histone acetylation in human colon cells. HT29 colon cancer cells were incubated with mixtures of butyrate, acetate and propionate and with the individual compounds as controls. Histone acetylation was determined with acid-urea gel electrophoresis and immunoblotting. Acetylated histones slowly increased over 24 h and persisted up to 72 h in butyrate-treated HT29 cells. Butyrate (5-40 mM) and propionate (20-40 mM) enhanced histone acetylation significantly after 24 h incubation, whereas acetate (2.5-80 mM) was ineffective. Mixtures of these SCFA also modulated histone acetylation, mainly due to additive effects of butyrate and propionate, but not due to acetate. In conclusion, physiological concentrations of propionate together with butyrate could have more profound biological activities than generally assumed. Together, these SCFA could possibly mediate important processes related to an altered transcriptional gene activation and thus contribute to biological effects possibly related to cancer progression or prevention.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17092367     DOI: 10.1017/bjn20061948

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  17 in total

Review 1.  Diet, the gut microbiome, and epigenetics.

Authors:  Meredith A J Hullar; Benjamin C Fu
Journal:  Cancer J       Date:  2014 May-Jun       Impact factor: 3.360

Review 2.  Manipulating Microbiota to Treat Atopic Dermatitis: Functions and Therapies.

Authors:  Md Jahangir Alam; Liang Xie; Yu-Anne Yap; Francine Z Marques; Remy Robert
Journal:  Pathogens       Date:  2022-06-02

3.  Influence of miRNA-106b and miRNA-135a on butyrate-regulated expression of p21 and Cyclin D2 in human colon adenoma cells.

Authors:  W Schlörmann; S Naumann; C Renner; M Glei
Journal:  Genes Nutr       Date:  2015-11-12       Impact factor: 5.523

4.  Primary human colonic mucosal barrier crosstalk with super oxygen-sensitive Faecalibacterium prausnitzii in continuous culture.

Authors:  Jianbo Zhang; Yu-Ja Huang; Jun Young Yoon; John Kemmitt; Charles Wright; Kirsten Schneider; Pierre Sphabmixay; Victor Hernandez-Gordillo; Steven J Holcomb; Brij Bhushan; Gar Rohatgi; Kyle Benton; David Carpenter; Jemila C Kester; George Eng; David T Breault; Omer Yilmaz; Mao Taketani; Christopher A Voigt; Rebecca L Carrier; David L Trumper; Linda G Griffith
Journal:  Med (N Y)       Date:  2020-08-06

5.  Differential susceptibility to colorectal cancer due to naturally occurring gut microbiota.

Authors:  Aaron C Ericsson; Sadia Akter; Marina M Hanson; Susheel B Busi; Taybor W Parker; Rebecca J Schehr; Miriam A Hankins; Carin E Ahner; Justin W Davis; Craig L Franklin; James M Amos-Landgraf; Elizabeth C Bryda
Journal:  Oncotarget       Date:  2015-10-20

6.  Trichostatin A effects on gene expression in the protozoan parasite Entamoeba histolytica.

Authors:  Gretchen M Ehrenkaufer; Daniel J Eichinger; Upinder Singh
Journal:  BMC Genomics       Date:  2007-07-05       Impact factor: 3.969

7.  Host microbiota modulates development of social preference in mice.

Authors:  Tim Arentsen; Henrike Raith; Yu Qian; Hans Forssberg; Rochellys Diaz Heijtz
Journal:  Microb Ecol Health Dis       Date:  2015-12-15

8.  Dietary inhibitors of histone deacetylases in intestinal immunity and homeostasis.

Authors:  R Schilderink; C Verseijden; W J de Jonge
Journal:  Front Immunol       Date:  2013-08-01       Impact factor: 7.561

9.  Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway.

Authors:  J Park; M Kim; S G Kang; A H Jannasch; B Cooper; J Patterson; C H Kim
Journal:  Mucosal Immunol       Date:  2014-06-11       Impact factor: 7.313

10.  The probiotic Propionibacterium freudenreichii as a new adjuvant for TRAIL-based therapy in colorectal cancer.

Authors:  Fabien J Cousin; Sandrine Jouan-Lanhouet; Nathalie Théret; Catherine Brenner; Elodie Jouan; Gwénaëlle Le Moigne-Muller; Marie-Thérèse Dimanche-Boitrel; Gwénaël Jan
Journal:  Oncotarget       Date:  2016-02-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.